nach oben

Erschienen in:

01.11.2021 | News item

PRAC Meeting Highlights

Einloggen, um Zugang zu erhalten

Excerpt

A recent meeting of the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) included assessments of ibrutinib and COVID-19 vaccines. …

European Medicines Agency (EMA). Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021. Internet Document : 29 Oct 2021. Available from: URL: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-25-28-october-2021

Titel: PRAC Meeting Highlights
Publikationsdatum: 01.11.2021
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-05215-2